Selected Publications

Click on the article title to access the PDF version

Bonilla P., McBride D., Shanks A., Kartik J., Bhan A., Porcu A. (2025) Evening blue light exposure during adolescence induces avoidance behaviors and rewires medial amygdala circuit. bioRxiv.

Bonilla P., Shanks A., Nerella Y., Porcu A. (2024) Effects of Chronic Light Cycle Disruption during Adolescence on Circadian Clock, Neuronal Activity Rhythms, and Behavior in Mice. Frontiers in Neuroscience 18:1418694.

Porcu A., Nilsson A., Booreddy S., Barnes S., Welsh D.K., Dulcis D. (2022) Seasonal changes in day length induce multi-synaptic neurotransmitter switching to regulate hypothalamic network activity and behavior. Science Advances 8, eabn9867.

.Porcu A., Riddle M., Dulcis D., Welsh D.K. (2018) Photoperiod-induced neuroplasticity in the circadian system. Neural Plasticity, 5147585.

Rudisell E., Weant K. and Porcu A. (2025) Chronotherapeutic considerations of benzodiazepine administration for agitation management in the emergency department. BMJ Mental Health 28:1-7.

Francis T.C. and Porcu A. (2023) Emotionally clocked out: cell-type specific regulation of mood and anxiety by the circadian clock system in the brain. Frontiers In Molecular Neuroscience 16:1188184.

Porcu A., Vaughan M., Nilsson A., Arimoto N., Lamia K., Welsh D.K. (2020) Vulnerability to helpless behavior is regulated by the circadian clock component CRYPTOCHROME in the mouse nucleus accumbens. PNAS 117(24):13771-13782.

Porcu A., Gonzalez R., McCarthy M.J. (2019) Pharmacological manipulation of the circadian clock: a possible approach to the management of bipolar disorder. CNS drug journal 33:981-999.

Porcu A., Mostallino R., Serra V., Melis M., Sogos V., Beggiato S., Ferraro L., Bettler B., Manetti F., Gianibbi B., Corelli F., Mugnaini C. and Castelli M.P. (2021) COR758, a Negative Allosteric Modulator of GABAB Receptors. Neuropharmacology 189:108537.

Porcu A., Melis M., Turecek R., Ullrich C., Mocci I., Bettler B., Gessa G.L., Castelli M.P. (2018) Rimonabant, the potent CB1 receptor antagonist, is a Gαi/o inhibitor. Neuropharmacology (133), 107-120.

Porcu A., Lobina C., Giunta D., Solinas M., Mugnaini C., Corelli F., Castelli M.P. (2016) In vitro and in vivo pharmacological characterization of a novel GABAB positive allosteric modulator: SSD114. European Journal of Pharmacology (791), 115-123.

Complete list of publications

Page updated

Google Sites

Report abuse